Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Seagen Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Pathologically-confirmed diagnosis of NHL or RCC
Relapsed, refractory, or progressive disease following at least 1 prior systemic therapy
Confirmed CD70 expression
Measurable disease, defined as at least 1 lesion \>1.5 cm in the greatest transverse diameter for patients with NHL, and at least 1 non-resectable tumor lesion \> or equal to 10 mm in diameter for patients with RCC
You may not be if
Previously received an allogeneic transplant
History of another primary malignancy that has not been in remission for at least 3 years
